US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

34.17

+0.60801.81%

Post-market: 33.56-0.6080-1.78%16:10 EDT

Volume:176

Turnover:6K

Market Cap:13.67M

PE:- -

High:34.17

Open:33.56

Low:34.17

Close:33.56

52wk High:34.86

52wk Low:25.79

Shares:400.00K

Float Shares:400.00K

Volume Ratio:0.31

T/O Rate:0.04%

Dividend:0.08

Dividend Rate:0.23%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Merck & Co Exec Says Timing for Raising the $70 Bln Forecast is "to be Determined" Adds "It's Coming"

THOMSON REUTERS

Biofrontera announces FDA approval of Ameluz supplemental new drug application

Sector Update: Healthcare Stocks Rise Premarket Monday

MT Newswires Live

U.S. Stocks on the MOVE-US Energy Stocks, Baldwin, Johnson & Johnson

J&J - Jnj Reports Rybrevant Plus Chemotherapy Extends Pfs2 by 10.8 Months in Nsclc

THOMSON REUTERS

Johnson & Johnson’s Rybrevant® (Amivantamab-Vmjw) Plus Chemotherapy Delivers Longest Reported Median Overall Survival in Egfr Exon 20 Insertion Mutation-Positive Lung Cancer

THOMSON REUTERS

J&J - Jnj Reports no New Safety Signals for Rybrevant Plus Chemotherapy in Nsclc Study

THOMSON REUTERS

Scholar Rock Wins FDA Approval for SMA Therapy

Potential Buyer Emerges for Johnson & Johnson's Orthopedics Unit

Scholar Rock price target raised to $84 from $76 at BMO Capital

Perspective Therapeutics Enters Cancer Clinical Trial Collaboration With Merck; Shares Up Pre-Bell

MT Newswires Live

CMS Secures Clinical Trial Green Light for Innovative Lupus Treatment Candidate

Perspective Therapeutics Partners with Merck to Test [212Pb]PSV359 with Keytruda in FAP-Α-Positive Solid Tumors

Perspective Therapeutics, - Co Sponsors Study; Merck Provides Pembrolizumab at no Cost

THOMSON REUTERS

Johnson & Johnson reports PAPILLON study meets primary endpoint

Market Chatter: Apollo Global in Talks to Buy J&J Orthopedics Unit for $20 Billion

MT Newswires Live

Nanobiotix announces updated safety, efficacy data from JNJ-1900 study

AstraZeneca's Breast Cancer Drug Etcamah Hits A Phase 3 Setback, Clouding Billions In Potential Sales

Options & Short Sell

Etcamah Falls Short in Late-Stage Breast Cancer Trial, Clouding AstraZeneca's Sales Outlook for the Drug

Johnson & Johnson Says Lung Cancer Drug Combination Extends Median Survival to Over 34 Months

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/BMED/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":34.1689,"timestamp":1789675200000,"preClose":33.5609,"halted":0,"volume":176,"hourTrading":{"tag":"盘后","latestPrice":33.5609,"preClose":34.1689,"latestTime":"16:10 EDT","volume":8,"amount":273.3512,"timestamp":1789675803872,"change":-0.608,"changeRate":-0.017794,"amplitude":0},"delay":0,"changeRate":0.018116319884151025,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"Closed","change":0.608,"latestTime":"09-17 16:00:00 EDT","open":33.5609,"high":34.1689,"low":34.1689,"amount":6029,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789718400000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":33.5609,"sharesOutstanding":360000,"nav":33.558586,"aum":13423434.4,"dividendRate":0.002333,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.5609,"preClose":34.1689,"latestTime":"16:10 EDT","volume":8,"amount":273.3512,"timestamp":1789675803872,"change":-0.608,"changeRate":-0.017794,"amplitude":0},"volumeRatio":0.305238,"impliedVol":0.0628,"impliedVolPercentile":0.004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.305238,"shares":400000,"dividePrice":0.0797,"high":34.1689,"amplitude":0,"preClose":33.5609,"low":34.1689,"week52Low":25.794,"pbRate":"--","week52High":34.86,"institutionHeld":0,"latestPrice":34.1689,"eps":0,"divideRate":0.002333,"volume":176,"delay":0,"ttmEps":0,"open":33.5609,"prevYearClose":30.32,"prevWeekClose":32.965,"prevMonthClose":33.8091,"prevQuarterClose":30.62,"fiveDayClose":32.8027,"twentyDayClose":34.7939,"sixtyDayClose":28.39},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667693199","title":"Merck & Co Exec Says Timing for Raising the $70 Bln Forecast is \"to be Determined\" Adds \"It's Coming\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693199","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693199?lang=en_us&edition=fundamental","pubTime":"2026-09-15 03:33","pubTimestamp":1789414394,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN4560EX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2125154778.USD","LU0868494708.USD","LU1201861249.SGD","LU0965509101.SGD","LU1934455194.USD","LU1983299246.USD","LU1934455277.USD","LU2357627491.SGD","LU2360032135.SGD","LU0320765646.SGD","LU1066051225.USD","LU0861579265.USD","SG9999002232.USD","LU1093756325.SGD","SG9999014542.SGD","LU0289961442.SGD","IE00BBT3K403.USD","BK4516","LU2361044865.SGD","LU2491049909.HKD","LU1989772923.USD","LU1699723380.USD","LU1057294990.SGD","LU1162221912.USD","LU1974910355.USD","LU0265550359.USD","LU1093756168.USD","IE0002141913.USD","LU1116320737.USD","LU1116320901.HKD","LU0985320562.USD","IE00BLSP4452.SGD","LU2089984988.USD","IE00B2B36J28.USD","LU0098860793.USD","LU2125909247.SGD","LU0058720904.USD","LU2125909593.SGD","LU1023059063.AUD","SG9999014559.SGD","PAWZ","BK4533","LU1037948541.HKD","IE00BFTCPJ56.SGD","BMED","LU0130102774.USD","LU1066053197.SGD","LU1585245621.USD","LU1066051498.USD","RXL","BK4588","SG9999015358.SGD","IE00BN8TJ469.HKD","LU2324357040.USD","LU1430594728.SGD","LU0266013472.USD","LU2361045086.USD","TRUH","LU0070302665.USD","GDOC","LU0106261372.USD","LU0203347892.USD","LU1061106388.HKD","LU0965508806.USD","LU0320765489.SGD","SG9999013999.USD","IE00BLSP4239.USD","VHT","LU1291159041.SGD","FTXH","LU2491050071.SGD","MRK","SG9999001176.SGD","IHE","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU1032466523.USD","IYH","LU2023250504.SGD","LU0238689110.USD","IE000M9KFDE8.USD","BK4559","LU2125154935.USD","LU0124676726.USD","LU2106854487.HKD","LU1941712264.USD","LU1066051811.HKD","LU0203345920.USD","LU0208291251.USD","LU0289739343.SGD","LU1571399168.USD","SGXZ57979304.SGD","LU0472753341.HKD","SG9999002224.SGD","LU2461242641.AUD","LU0511384066.AUD","BK4585","IXJ","SG9999014575.USD","HRTS","LU1989771016.USD","SG9999014567.USD","IE00B1BXHZ80.USD","XLV","LU0006306889.USD","LU0823416689.USD","LU2361044949.HKD","LU0211331839.USD","LU0965509010.AUD","IE0009355771.USD","FHLC","LU0069063385.USD","LU0859254822.USD","LU1923622614.USD","LU0980610538.SGD","LU1989772840.SGD","LU2468319806.SGD","LU0122379950.USD","LU0234572021.USD","LU0289739699.SGD","BK4534","LU0130517989.USD","LU1929549753.HKD","LU2023250843.SGD","SG9999001176.USD","LU0057025933.USD","LU0432979614.USD","LU1035773651.USD","LU0868494617.USD","LU0648001328.SGD","LU1917777945.USD","LU0265550946.USD","LU1037948897.HKD","SG9999015341.SGD","IE00BJJMRZ35.SGD","LU0689626769.HKD","LU1069347547.HKD","LU1934455863.HKD","LU2433249047.HKD","LU1941712348.USD","LU2112291526.USD","LU0965509283.SGD","SG9999001440.SGD","JDOC","LU0942090050.USD","IE00BSNM7G36.USD","BK4007","LU0477156953.USD","LU2491050154.USD","BK4550","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661630","title":"Biofrontera announces FDA approval of Ameluz supplemental new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661630","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661630?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:35","pubTimestamp":1789392922,"startTime":"0","endTime":"0","summary":"Biofrontera (BFRI) announced that the FDA has approved the company’s supplemental new drug application, or sNDA, for Ameluz topical gel, 10%, in co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","XLVX","SYNB","IBB","IEIH","BMED","GNMX","RSPH","NVIB","BFRI","MRNX","IDNA","TECB","MRNY","LABU","TBXU","BBP","FRTY","GDOC","BK4585","IYH","MEDI","BK4007","BK4588","PINK","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667970669","title":"Sector Update: Healthcare Stocks Rise Premarket Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2667970669","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667970669?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:17","pubTimestamp":1789391865,"startTime":"0","endTime":"0","summary":"Healthcare stocks were rising premarket Monday, with the State Street Health Care Select Sector SPDR ETF  advancing by 1.2% and the iShares Biotechnology ETF  0.3% higher.GSK  licensor Hansoh Pharmaceutical reported that a phase 3 trial evaluating risvutatug rezetecan, or Ris-Rez, against commonly used topotecan in patients with relapsed small-cell lung cancer met its primary endpoint. GSK stock was up more than 4% pre-bell.Astrazeneca  shares were up more than 2% after the company said a late-stage study of its drug Enhertu showed a six-month improvement in median progression-free survival as a first-line treatment for advanced HER2-mutant non-small cell lung cancer.Johnson & Johnson  stock was up more than 1% after the company said a phase 3 trial of its lung cancer drug Rybrevant combined with chemotherapy resulted in a median overall survival of 34.3 months. Separately, The Wall Street Journal reported that Apollo Global Management  is in talks to acquire Johnson & Johnson's hips-a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JDOC","GSK","IXJ","LU1244550577.SGD","LU1043141123.HKD","PJP","TRUH","GDOC","LU2750360641.GBP","PRVT","AAUM","XBI","LBO","FTXH","LU0069063385.USD","BMED","AZN","LU2471134796.USD","IE0009355771.USD","IE00B4R5TH58.HKD","JNJ","GSKH","IE00BSNM7G36.USD","GPZ","RXL","IBB","LU2133065610.SGD","XLV","FHLC","LU1935042991.SGD","LU2213496289.HKD","LU1280957306.USD","GSK.UK","MEDX","HCSG","LU0203347892.USD","LU0289739699.SGD","SGXZ80539844.SGD","LU0912757837.SGD","IYH","LU1718418525.SGD","LU0053666078.USD","APO","LABU","LU1228905037.USD","VHT","LU0210536198.USD","IHE","BK4550","AZNH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667666922","title":"U.S. Stocks on the MOVE-US Energy Stocks, Baldwin, Johnson & Johnson","url":"https://stock-news.laohu8.com/highlight/detail?id=2667666922","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667666922?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:45","pubTimestamp":1789389940,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-US energy stocks, Baldwin, Johnson & JohnsonMarch 20 (Reuters)-Futures tracking the Nasdaq 100 index led early declines on Monday, dragged by a selloff in AI heavyweights ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL6N4560P8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2191332357.HKD","LU1935043536.SGD","LU2125909759.SGD","LU2129689514.USD","LU0256331488.USD","NVD","NVDD","LU1935042991.SGD","GB00BDT5M118.USD","LU0444973449.USD","IE00B1BXHZ80.USD","LU0964807845.USD","LU0345781412.USD","LU2764263039.SGD","VHT","LU0498741114.HKD","LU0417517546.SGD","LU0943347566.SGD","LU2471134796.USD","LU2087625088.SGD","LU2430703095.HKD","CRBP","IE0004445015.USD","LU0006306889.USD","04335","LU2720916845.USD","LU1084165304.USD","LU2361044865.SGD","LU1430597077.USD","LU2360032135.SGD","LU1235294995.USD","LU0157215616.USD","LU0122376428.USD","ILDR","SNVDAmain","LU0787776722.HKD","SOXY","LU1435385759.SGD","GAMR","LU1585245621.USD","IE00BQXX3D17.EUR","LU0114720955.EUR","LU1989764664.SGD","SG9999001424.SGD","SG9999014906.USD","2NVD.UK","LU1169590202.USD","LU0345769128.USD","LU2047632596.USD","BK4549","LU0061475181.USD","IE0000B7K699.USD","LU2133065610.SGD","SG9999014880.SGD","LU2487616109.SGD","LU2505996509.AUD","LU1623119135.USD","IE000KEQY171.SGD","LU1037948897.HKD","SG9999015945.SGD","SGXZ57979304.SGD","THMR","IE0002141913.USD","JDOC","LEGR","LU0795875169.SGD","LU0433182093.SGD","HK0000532082.HKD","LU2237443978.SGD","LU1162221912.USD","LU2637965513.SGD","LU1267930573.SGD","IE00BD6J9T35.USD","LU0251131958.USD","IE00B19Z8X17.USD","MRVL","LU2249611893.SGD","LU0708994859.HKD","LU0143551892.USD","LU2237443622.USD","IE00BQXX3C00.GBP","LU2552382058.USD","IE00BJTD4V19.USD","LU1992135472.HKD","HK0000304805.HKD","LU2756315664.SGD","LU2065170008.USD","IE00BDRTCR15.USD","LU2756315318.SGD","GLDN","BK4573","LU0724618789.USD","LU1868837136.USD","AGMI","LU0786609619.USD","LU1069347547.HKD","LU0081259029.USD","LU0823434583.USD","LU1066051811.HKD","LU2112291526.USD","FTEC","LU2357305700.SGD","LU2543165471.USD","LU0128525689.USD","MRVX","LU1732799900.SGD","TRFK","GDOC","SG9999001440.SGD","LU1035773651.USD","LU2458330243.SGD","LU0820562030.AUD","LU0321505439.SGD","LU2111349929.HKD","LU1923622291.USD","LU0820561909.HKD","AFK","LU2471134952.CNY","AIQ","LU1242518857.USD","LU1551013425.SGD","IE00B19Z9505.USD","IE000BZT7R73.USD","LU0353189763.USD","LU1894683348.USD","LU0724617625.USD","LU0861579265.USD","LU2125154935.USD","BK4608","LU1228905037.USD","LU2322448791.USD","PJP","LU0320765646.SGD","IE00B5949003.HKD","NVD2.UK","LU0175139822.USD","LU1803068979.SGD","IE00BSNM7G36.USD","LU2065171311.SGD","LU1868837565.USD","LU1718418525.SGD","BK4201","IE0004086264.USD","LU0345780521.USD","LU0708995401.HKD","CHPX","LU0029864427.USD","LU1732800096.USD","LU2458330169.SGD","LU1169589451.USD","HK0000320223.HKD","AMUU","TYLG","BK4533","TRUN","LU0077335932.USD","LU1144417596.USD","LU1935042215.USD","NVD3.UK","BK4585","BK4550","AMDY","LU2361045086.USD","LU1868836757.USD","IE00BFTCPJ56.SGD","LU2125909916.SGD","LU0109392836.USD","LU2087621335.USD","LU0323240290.USD","BK4141","LU2456880835.USD","LU2322448957.HKD","LU0203345920.USD","LU1153585028.USD","LU0557290698.USD","BK4551","LU1861215975.USD","LU0738911758.USD","LU1983260115.SGD","LU2100268510.USD","LU0985320562.USD","CHAT","LU0211326839.USD","LU0323591593.USD","LU1839511570.USD","LU2023250330.USD","HK0000306701.USD","LU2602419157.SGD","MRVU","LU1992135399.USD","IHE","DTCR","SG9999001176.USD","LU0265550359.USD","LU0048584097.USD","LU1221951046.USD","LU2381873111.SGD","DRIV","LU0353189680.USD","LU2413666426.HKD","LU2473716301.USD","IE000YTNTUN2.SGD","HK0000320264.USD","XLK","LU2498475776.HKD","LU2213496289.HKD","IE00B2B36J28.USD","LU2097344431.USD","ELMT","LU1023059063.AUD","LU2098885051.SGD","LU1823568750.SGD","SG9999000418.SGD","IE0005OL40V9.USD","BK4568","IE00B3T34201.USD","IE00BDCRKT87.USD","LU0498741890.SGD","LU0345768740.USD","LU1691799644.USD","IYH","LU1923623000.USD","IE00BKPKM429.USD","SG9999002232.USD","NVDU","LU0211328371.USD","LU1280957306.USD","LU0823414551.USD","IE00B19Z3581.USD","IE0009355771.USD","SG9999015952.SGD","LU1645745479.HKD","LU2272731865.HKD","SG9999001176.SGD","LU0154236417.USD","SGXZ80539844.SGD","IE000WAW04H5.SGD","IBRN","IE00BDGV0183.EUR","XOMX","IE00BMPRXN33.USD","LU1291159041.SGD","LU0174119429.USD","LU0011850046.USD","LU2326559502.SGD","DAMD","BK4515","IE00B19Z3B42.SGD","LU0133085943.USD","LU1043141396.HKD","LU0096362180.USD","NVYY","HK0000819398.USD","BK4017","LU0300736062.USD","LU0426412945.USD","LU2430703178.SGD","LU1202635105.USD","LU1712237335.SGD","LU0426417589.USD","BK4522","IE00BN8TJ469.HKD","LU2237443895.HKD","LU1244550494.USD","LU1582987324.SGD","LU0256863811.USD","LU0965509010.AUD","LU1804176565.USD","BK4527","LU2065169927.USD","LU0979878070.USD","LU0942090050.USD","LU1934455277.USD","LU0203201768.USD","LU1951200564.SGD","LU0053666078.USD","AMDD","LU0127658192.USD","LU0130517989.USD","LU0949170772.SGD","LU1196500208.SGD","LU2092627202.USD","NVDY","LU0052756011.USD","LU0057025933.USD","AMDC","BK4602","LU2294711713.HKD","IE00BN29S564.USD","LU0323239441.USD","IE00BKDWB100.SGD","LU1223082196.USD","LU2271345857.HKD","LU2750360641.GBP","LU0640476718.USD","LU2089284900.SGD","JGRO","LU0726765562.USD","LU1923622614.USD","LU2552382132.HKD","LU2860962120.EUR","IE000W1ABFV2.USD","LU1935042488.USD","07388","SLVP","SMH","LU0238689110.USD","BK4559","LU0354030511.USD","LU2125909247.SGD","LU1267930490.SGD","NWMX","LU2491050071.SGD","LU0203202063.USD","SG9999017495.SGD","LU0310799852.SGD","ARTY","LU1721428933.USD","LU0661504455.SGD","IE00BGHQF524.EUR","LU1880398471.USD","LU2430703251.USD","ABFL","SG9999015358.SGD","LU2462157665.USD","AMYY","LU0868494617.USD","LU2413666699.HKD","BK4588","LU1674673428.USD","LU0162691827.USD","3NVD.UK","FXL","IE00B4JS1V06.HKD","NVDS","DRLL","LU0368265418.SGD","LU2242650005.HKD","LU1868836914.USD","LU0276348264.USD","LU1852331112.SGD","INT","LU1303367103.USD","IE00BZ1G4Q59.USD","LU0289960550.SGD","LU1989772923.USD","OILT","LU0061474960.USD","SG9999014575.USD","LU2433249047.HKD","BK4535","IE00BYXW3230.USD","TTEQ","LU0792757196.USD","LU0256863902.USD","IE00BWXC8680.SGD","BK4503","LU0211326755.USD","IE0004445239.USD","LU0654597011.USD","LU0957791311.USD","LU0274383776.USD","COP","LU2054465674.USD","LU2361044949.HKD","LU0444971666.USD","LU2764262908.HKD","MVLL","SG9999014914.USD","NVDS.UK","LU2065171402.SGD","LU0957808578.USD","LU0266512473.USD","LINT","LU0985489474.SGD","LU2023250504.SGD","LU1023059493.AUD","LU2097344357.USD","LU0496367417.USD","LU0882574139.USD","LU1699723380.USD","BK4570","LU0303823156.USD","LU1316542783.SGD","LU0075056555.USD","LU0303821028.USD","LU2360106780.USD","LU0055631609.USD","BK4566","LU0878866978.SGD","ERX","LU0234572021.USD","LU1983299246.USD","LU1366192091.USD","LU0061474705.USD","NVC","CVX","LU0098860793.USD","LU0069063385.USD","FTXH","XNTK","LU0048573561.USD","FTXN","IE00B3CCJ963.GBP","VDE","IE00BK4W5M84.HKD","BK4139","SAMD0main","LU2089283258.USD","SG9999015986.USD","LU1242518931.SGD","INTC","LU2063271972.USD","LU1244550577.SGD","LU0094547139.USD","LU1929549753.HKD","ROM","BK4077","BK4516","LU1400636574.HKD","LU2471134523.USD","IE00B42XCP33.USD","IE0004091025.USD","LU1571399168.USD","CLSE","AMDG","LU0689472784.USD","IE00BJLML261.HKD","LU0898699433.AUD","SG9999002224.SGD","LU1821325948.USD","LU0354030438.USD","LU2463028550.USD","FHLC","LU0976567544.SGD","LU0496365809.HKD","LU0472753341.HKD","LU1642822529.SGD","LU1791710400.SGD","LU1815336760.USD","LU0630314457.HKD","LU2236285917.USD","XOMO","LU0345769631.USD","IE00BVYPNV92.GBP","IE0003U64NQ7.SGD","IXC","LU0965509101.SGD","LU0823414478.USD","PSI","DIPS","BK4604","HK0000914660.USD","IE000Q6AESB8.SGD","TRUM","SG9999015978.USD","NVDX","BMED","IE00BHPRN162.USD","ANV","LU1582986433.USD","IYE","AU","USXF","IE00B5TLWC47.USD","LU0096364046.USD","LU0208291251.USD","LU1974910355.USD","LU0082616367.USD","BK4213","LU1489326972.SGD","ESUM","LU2357627491.SGD","NVDB","LU2746668974.SGD","MEDX","SG9999014567.USD","LU1934455863.HKD","SG9999002521.SGD","SGXZ23171101.USD","LU0642271901.SGD","LU1150488135.SGD","LU0342679015.USD","LU2264538146.SGD","LU0106261372.USD","IE00BJTD4N35.SGD","LU0476273544.USD","LU1633808545.USD","LU1951198990.SGD","LU0672654240.SGD","LU2462591277.SGD","LU0158827948.USD","LU0345770993.USD","LU1894683264.USD","XLV","LU0109391861.USD","LU1116320737.USD","LU0097036916.USD","GDMN","LU0320765059.SGD","LU0390134368.USD","LU0823421333.USD","LU2279689827.SGD","BK4567","LU0368265764.SGD","LU2168564495.EUR","SGXZ81514606.USD","LU2211815571.USD","BK4579","EOG","LU0300736492.USD","LU2452424414.USD","LU2394011477.USD","LU2931357623.SGD","LU2347655156.SGD","LU1261432733.SGD","LU0511384066.AUD","CNAV","IE00BLSP4452.SGD","LU1989772840.SGD","LU1917777945.USD","LU1223083913.SGD","SMHX","IE000MB6IJN5.SGD","LU1400636491.USD","LU1366333091.USD","NVDA","IE0002270589.USD","LU2125909593.SGD","IE0009356076.USD","LU2552382215.SGD","LU0289739343.SGD","LU1861558580.USD","IXJ","LU2168564149.EUR","VGT","LU1674673691.USD","IE00B3S45H60.SGD","LU1043141123.HKD","LU0210536198.USD","LU2417539215.USD","LU0056508442.USD","LU2471134879.HKD","AMDW","LU2999663052.SGD","LU2355687059.USD","LU0648000940.SGD","LU0314106906.USD","IE00BFXG1179.USD","PXE","LU0203347892.USD","LU1032466523.USD","LU2125154778.USD","LU0225283273.USD","XOMZ","EFIV","BK4161","LU0107464264.USD","LU0980610538.SGD","LU0124676726.USD","NVDG","BK4598","GDX","AIS","IE00BVYPNW00.USD","LU1069344957.HKD","LU0320765489.SGD","LU1037948541.HKD","LU2491050154.USD","LU2764263203.CNY","LU1064131342.USD","WISE","LU1223082519.USD","BK4512","LU1267930813.SGD","LU2461242641.AUD","LU1868836591.USD","LU0689626769.HKD","IE0001KFT4U8.USD","LU2462591350.SGD","LU2491049909.HKD","NULC","NVDL","LU0266013472.USD","LU1150488218.USD","LU1548497426.USD","09788","LU1003077747.HKD","LU2237443465.HKD","LU1551013342.USD","LU1496350502.SGD","TRUH","BK4548","IEO","BK4532","LU0321505868.SGD","FCG","LU2023251221.USD","IE0034235303.USD","IE00B7KXQ091.USD","IE000SO60NU8.SGD","LU1228905540.USD","LU1400636657.SGD","LU2286300806.USD","CMAG","IE000ITXATA3.USD","DIG","IE00BZ199S13.USD","LU1914381329.SGD","LU1582986359.USD","LU2028103732.USD","LU0072461881.USD","IE00B4YYXB79.USD","IE00B7SZLL34.SGD","LU0553294199.USD","LU2129689605.HKD","LU2168564222.USD","ESLG","LU1861127337.USD","SG9999014559.SGD","LU1670756490.USD","LU2089985449.USD","LU0143863784.USD","LU0742534661.SGD","LU0187121727.USD","LU2106854487.HKD","GXPE","LU0345768153.USD","LU2420271590.USD","WEEI","LU0466842654.USD","SG9999014542.SGD","SPTE","LU2290526834.HKD","IE00B4R5TH58.HKD","LU0128525929.USD","LU1267930227.SGD","SNVD.UK","LFGY","LU1861220033.SGD","LU1102505762.USD","LU0316494557.USD","LU1989764748.USD","IE00BQXX3F31.USD","LU0080751232.USD","LU1232071149.USD","LU1979441026.SGD","BK4605","LU2462611646.USD","IE00BMPRXR70.SGD","LU0198837287.USD","IE000M9KFDE8.USD","IE00B3PB1722.GBP","LU1121112475.USD","LU1791710582.SGD","NVIW.SI","LU0612318971.USD","LU3102509885.SGD","LU0267386448.USD","SG9999014898.SGD","BK4581","IE000F7OJYX1.SGD","IE00BGHQF631.EUR","LU1629891620.HKD","LU0265550946.USD","FENY","LU0889565833.HKD","XLE","LU2954938101.SGD","LU2237443549.SGD","LU1145028129.USD","SINTCmain","BK4614","INYY","LU2129689431.USD","AMD","CHPS","IE00BLSP4239.USD","IETC","LU0823421416.USD","LU0330918003.SGD","LU1057294990.SGD","LU1066051498.USD","LU1127390331.HKD","LU0889566641.SGD","LU2092937148.SGD","INTW","LU2272731600.USD","SGXZ31699556.SGD","LU1201861249.SGD","BK4554","LU0868494708.USD","LU0058720904.USD","HK0000914686.HKD","LU0138981039.USD","LU0477156953.USD","LU1429558221.USD","LU1815333072.USD","NVII","BK4504","FAI","LU1496350171.SGD","TTXU","LU1935043452.HKD","IE00BK4W5L77.USD","LU0308772762.SGD","RUM","LU0310800379.SGD","LU2347655073.USD","FTXL","BK4612","LU1244550221.USD","LU0289739699.SGD","LU2077746001.SGD","IE0034235295.USD","IE00B3M56506.USD","LU0823434740.USD","LU1883866441.USD","LU1935043023.USD","LU0266512127.USD","LU2244417387.USD","LU1988902786.USD","LU0289961442.SGD","LU0612318385.USD","BK4587","LU2505996681.GBP","THNR","XOM","LU1880398554.USD","LU1032955483.USD","LU0068578508.USD","LU0251142724.SGD","SG9999018865.SGD","LU1868838027.USD","LU2148611432.USD","LU2237438978.USD","LU1720051017.SGD","LU0820561818.USD","SG9999015341.SGD","LU0310800965.SGD","SG9999018857.SGD","TEK","BAI","LU0278409577.USD","LU2247934214.USD","LU0348723411.USD","LU2506951792.HKD","LU1778281490.HKD","LU0215105999.USD","LU1201861165.SGD","IE00BJJMRX11.SGD","SG9999001143.SGD","LU0528227936.USD","LU1323610961.USD","LU0130102774.USD","LU1221951129.SGD","BK4529","LU0494093205.USD","SOXQ","FDTX","LU0251132253.USD","LU0143863198.USD","LU0070217475.USD","LU2265009873.SGD","SOXX","LU0912757837.SGD","BK4575","AIFD","LU0149725797.USD","AUMI","LU0965509283.SGD","IXN","LU0072462426.USD","LU0859254822.USD","LU0882574055.USD","LU0788109121.HKD","LU1989771016.USD","LU2108987350.USD","LU0234570918.USD","CNEQ","VT","IE00BFSS7M15.SGD","IE00B2Q91V27.USD","IE00BJT1NW94.SGD","LU0345780281.USD","IE00B1XK9C88.USD","RXL","LU2237957811.SGD","LU0210533765.USD","FMTL","LU1119994496.HKD","LU2250418816.HKD","LU0788109477.HKD","IE00B775H168.HKD","LU2750360997.AUD","NVDW","IE00B19Z8W00.USD","AIPI","AMDS","LU1720051108.HKD","IE00B3SWFQ91.USD","LU1506573853.SGD","SNPE","SG9999004303.SGD","HK0000304797.USD","WUGI","JNJ","LU2168564065.EUR","BK4592","HK0000306685.HKD","LU0211327993.USD","LU2468319806.SGD","BK4007","LU1061106388.HKD","LU0130103400.USD","LU1046421795.USD","LU0347712357.USD","LU1074936037.SGD","LU0079474960.USD","BK4534","LU0648001328.SGD","LU0545562505.USD","LU0965508806.USD","AMDU","LU2592432038.USD","LU1934455194.USD","LU1035775433.USD","LU1116320901.HKD","NEMG","LU2089984988.USD","LU0122379950.USD","SRRK","TEXU","LU1059921491.USD","LU0719512351.SGD","LU0395794307.EUR","LU2403377893.USD","LU0345770308.USD","SHOC","LU1102505929.USD","NVDO","LU2083900584.USD","LU0070302665.USD","SGXZ99366536.SGD","LU0545039389.USD","LU1814569148.SGD","SGXZ51526630.SGD","LU1066053197.SGD","LU0994945656.USD","LU1267930730.SGD","LU2237443382.USD","IE00B775SV38.USD","LU2168563687.JPY","LU1430594728.SGD","LU0432979614.USD","SGDM","LU2242649171.HKD","LU0456854461.SGD","LU2357125470.USD","IE00BBT3K403.USD","IE00BMPRXQ63.HKD","LU2746668461.USD","LU2896262040.SGD","AMDL","IE0034235188.USD","LU0788108826.HKD","LU1066051225.USD","AUAU","IE0009G5SDU7.USD","LU2272731782.SGD","IGE","LU1861559042.SGD","07788","LU0795875086.SGD","LU1868837300.USD","QQQA","BK4173","IE00BKVL7J92.USD","BK4543","LU0345780950.USD","GTEK","NEM","USD","IE00BJJMRY28.SGD","LU0158827781.USD","IE00BFSS8Q28.SGD","LU0683600562.USD","LU0788109394.HKD","IE00BJJMRZ35.SGD","NVDQ","LU2360107168.USD","SG9999013999.USD","LU2102340556.USD","LU0170899867.USD","LU0210528500.USD","METV","AGOX","LU2237957902.USD","BWIN","LU1582987597.SGD","09388"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667663696","title":"J&J - Jnj Reports Rybrevant Plus Chemotherapy Extends Pfs2 by 10.8 Months in Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2667663696","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667663696?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:33","pubTimestamp":1789389218,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN4530XA:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BLSP4239.USD","LU1074936037.SGD","TRUH","IE00B3PB1722.GBP","RXL","FHLC","MEDX","SG9999001440.SGD","LU2129689431.USD","BMED","LU2430703178.SGD","IE00B1BXHZ80.USD","VHT","XLV","IE00BGHQF631.EUR","LU1894683348.USD","IXJ","LU1894683264.USD","LU0912757837.SGD","SGXZ80539844.SGD","IYH","LU1291159041.SGD","LU0203347892.USD","IE0000B7K699.USD","LU0689472784.USD","IE00BZ1G4Q59.USD","FTXH","LU2896262040.SGD","IE000SO60NU8.SGD","IE00BJT1NW94.SGD","LU0203345920.USD","LU0466842654.USD","LU0345769631.USD","LU1196500208.SGD","BK4532","LU0787776722.HKD","LU1023059063.AUD","JNJ","JDOC","SG9999002224.SGD","SGXZ57979304.SGD","LU1989771016.USD","LU1066051225.USD","GDOC","IE000F7OJYX1.SGD","LU0234570918.USD","LU0792757196.USD","LU1935042991.SGD","IHE","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667663386","title":"Johnson & Johnson’s Rybrevant® (Amivantamab-Vmjw) Plus Chemotherapy Delivers Longest Reported Median Overall Survival in Egfr Exon 20 Insertion Mutation-Positive Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2667663386","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667663386?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:33","pubTimestamp":1789389218,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN4530XA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1914381329.SGD","RXL","FHLC","LU1057294990.SGD","IYH","BK4007","LU1228905540.USD","BMED","IE00B3PB1722.GBP","LU0426412945.USD","JNJ","IE000BZT7R73.USD","SGXZ80539844.SGD","LU0511384066.AUD","LU0234572021.USD","LU0795875086.SGD","IXJ","LU0289739343.SGD","SG9999001176.SGD","LU2213496289.HKD","GDOC","LU0689626769.HKD","LU0472753341.HKD","TRUH","LU1244550494.USD","XLV","LU2471134523.USD","IE00B1BXHZ80.USD","LU1228905037.USD","LU0820562030.AUD","PJP","IE00BZ1G4Q59.USD","MEDX","LU1032466523.USD","IE000M9KFDE8.USD","LU1732799900.SGD","LU1506573853.SGD","IE00B19Z3581.USD","LU2417539215.USD","LU0122379950.USD","LU0689472784.USD","IE0001KFT4U8.USD","LU0964807845.USD","LU1145028129.USD","LU1983299246.USD","VHT","IHE","LU0912757837.SGD","FTXH","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667364666","title":"J&J - Jnj Reports no New Safety Signals for Rybrevant Plus Chemotherapy in Nsclc Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2667364666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667364666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:33","pubTimestamp":1789389218,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN4530XA:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1032466523.USD","JDOC","BK4581","VHT","LU2129689514.USD","IHE","IYH","LU0162691827.USD","IE00B1BXHZ80.USD","LU0994945656.USD","LU1551013425.SGD","LU0069063385.USD","LU1074936037.SGD","LU1506573853.SGD","SG9999013999.USD","TRUH","LU2129689605.HKD","BMED","IE00BFXG1179.USD","LU1244550577.SGD","IE00BZ1G4Q59.USD","LU0072461881.USD","LU0203345920.USD","BK4592","IE000BZT7R73.USD","LU0234572021.USD","FTXH","RXL","LU0787776722.HKD","LU2487616109.SGD","MEDX","FHLC","GDOC","IXJ","JNJ","LU0203347892.USD","PJP","IE0002270589.USD","SG9999001176.USD","BK4585","LU0985320562.USD","XLV","LU0122379950.USD","LU0820561818.USD","LU1221951129.SGD","LU2471134952.CNY","LU0964807845.USD","LU0426412945.USD","LU0098860793.USD","LU0345769631.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667066661","title":"Scholar Rock Wins FDA Approval for SMA Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667066661","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667066661?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:32","pubTimestamp":1789389127,"startTime":"0","endTime":"0","summary":"The latest update is out from Scholar Rock Holding ( ($SRRK) ). On September 11, 2026, Scholar Rock announced U.S. FDA approval of ISEMBYLD (apiteg...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","MRNX","IBB","GDOC","LFSC","IYH","TBXU","LABU","IDNA","GNMX","BBP","FRTY","BMED","IEIH","RSPH","PSCH","PINK","XLVX","BK4588","TECB","BK4585","MRNY","SYNB","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199352552","title":"Potential Buyer Emerges for Johnson & Johnson's Orthopedics Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=1199352552","media":"Deep News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199352552?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:41","pubTimestamp":1789386088,"startTime":"0","endTime":"0","summary":"The divestiture of Johnson & Johnson's orthopedics business has taken a significant step forward, with a leading asset management firm now in advanced discussions to acquire the division.According to...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BDGV0183.EUR","LU1506573853.SGD","SG9999001440.SGD","LU1228905037.USD","LU0994945656.USD","LU1196500208.SGD","LU1674673428.USD","LU0289739343.SGD","LU0820561818.USD","LU0820562030.AUD","LU1894683264.USD","LU2112291526.USD","TRUH","IE0002270589.USD","SG9999001176.SGD","LU2236285917.USD","LU2602419157.SGD","IE00BZ1G4Q59.USD","LU1732799900.SGD","LU0943347566.SGD","LU1894683348.USD","LU0345769631.USD","IE00BKVL7J92.USD","LU0114720955.EUR","LU1983299246.USD","LU2468319806.SGD","BK4007","IE000SO60NU8.SGD","LU2756315318.SGD","LU2430703095.HKD","IE00B4R5TH58.HKD","LU2347655156.SGD","LU2133065610.SGD","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","IE000WAW04H5.SGD","LU1043141396.HKD","LU1585245621.USD","LU2471134796.USD","LU1261432733.SGD","IE00B1BXHZ80.USD","BK4534","GDOC","BK4559","LU1244550221.USD","BK4588","SG9999002224.SGD","LU1221951046.USD","BK4585","LU0098860793.USD","IE0002141913.USD","LU0234572021.USD","LU0792757196.USD","LU1914381329.SGD","LU1032955483.USD","LU1935042991.SGD","LU2505996681.GBP","LU2896262040.SGD","LU0203347892.USD","LU1145028129.USD","LU2471134879.HKD","LU2129689431.USD","LU2129689605.HKD","SG9999001176.USD","LU2213496289.HKD","LU0964807845.USD","FTXH","LU2592432038.USD","IE000MB6IJN5.SGD","LU0426417589.USD","LU2089984988.USD","IE0000B7K699.USD","LU0210536198.USD","BK4504","LU1551013342.USD","LU1228905540.USD","BK4550","BK4581","BK4568","IE000BZT7R73.USD","SG9999013999.USD","LU1066051225.USD","LU1929549753.HKD","LU1244550577.SGD","LU0122379950.USD","LU1496350502.SGD","LU0640476718.USD","BK4532","IXJ","LU2471134952.CNY","IHE","LU0320765646.SGD","LU0912757837.SGD","LU0162691827.USD","LU1629891620.HKD","BK4533","LU0203345920.USD","IE00BBT3K403.USD","FHLC","LU2403377893.USD","LU0210528500.USD","LU0426412945.USD","IE00B3T34201.USD","LU1291159041.SGD","LU0472753341.HKD","LU1066051498.USD","LU1057294990.SGD","LU0689626769.HKD","IYH","LU2750360997.AUD","IE00BFTCPJ56.SGD","LU1162221912.USD","LU2430703251.USD","LU1778281490.HKD","RXL","LU1430594728.SGD","VHT","XLV","LU1280957306.USD","LU2505996509.AUD","LU0057025933.USD","LU1244550494.USD","LU0345770308.USD","LU1066051811.HKD","LU2129689514.USD","LU0053666078.USD","LU0069063385.USD","IE000M9KFDE8.USD","LU1043141123.HKD","IE00BLSP4452.SGD","IE00BVYPNW00.USD","LU0511384066.AUD","MEDX","LU0124676726.USD","IE0001KFT4U8.USD","IE00BGHQF631.EUR","SGXZ57979304.SGD","IE00B42XCP33.USD","LU0070217475.USD","LU0432979614.USD","LU0683600562.USD","LU0889566641.SGD","LU1059921491.USD","LU2756315664.SGD","LU0234570918.USD","IE00BVYPNV92.GBP","IE00BN8TJ469.HKD","LU0795875086.SGD","LU1066053197.SGD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU1221951129.SGD","LU2456880835.USD","IE00B2B36J28.USD","LU1989771016.USD","PJP","BK4592","BMED","LU1674673691.USD","LU2750360641.GBP","LU2471134523.USD","LU2417539215.USD","IE00BLSP4239.USD","LU0795875169.SGD","IE000F7OJYX1.SGD","LU0289961442.SGD","LU1551013425.SGD","LU1718418525.SGD","LU2487616109.SGD","LU0820561909.HKD","LU0345770993.USD","LU2023250330.USD","LU0072461881.USD","LU1032466523.USD","LU0985320562.USD","LU0545562505.USD","IE00B3PB1722.GBP","LU1732800096.USD","SGXZ80539844.SGD","LU1121112475.USD","LU0882574055.USD","IE00B7SZLL34.SGD","LU0289739699.SGD","LU0787776722.HKD","LU1267930813.SGD","LU0058720904.USD","JNJ","LU1061106388.HKD","SG9999002232.USD","IE00B19Z3581.USD","LU0345769128.USD","LU1074936037.SGD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU0466842654.USD","JDOC","LU0689472784.USD","LU2430703178.SGD","IE00BFXG1179.USD","IE0034235303.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667134663","title":"Scholar Rock price target raised to $84 from $76 at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2667134663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667134663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:36","pubTimestamp":1789385772,"startTime":"0","endTime":"0","summary":"BMO Capital raised the firm’s price target on Scholar Rock (SRRK) to $84 from $76 and keeps an Outperform rating on the shares. The FDA approval of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","BMED","GNMX","LABU","TECB","MRNX","IYH","BK4139","PINK","IBRN","IBB","RSPH","TBXU","THNR","LFSC","BK4588","MEDI","SRRK","IDNA","PSCH","BBP","FRTY","BK4585","GDOC","IEIH","NVIB","MRNY","XLVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667668547","title":"Perspective Therapeutics Enters Cancer Clinical Trial Collaboration With Merck; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668547","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668547?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:10","pubTimestamp":1789384248,"startTime":"0","endTime":"0","summary":"Perspective Therapeutics  has signed a clinical trial collaboration with Merck  for the potential evaluation of a combination cancer treatment, Perspective Therapeutics said Monday.The agreement supports the evaluation of Perspective Therapeutics' PSV359 targeted alpha-particle therapy in combination with Merck's Keytruda.The combination will be assessed under an amendment to the company's ongoing phase 1/2a study in patients with certain types of non-small cell lung and colorectal cancers, Perspective Therapeutics said.Perspective Therapeutics shares were up 6.2% in premarket activity, while Merck rose 1.3%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BLSP4452.SGD","LU0320765489.SGD","PPH","XLV","IXJ","IE00BSNM7G36.USD","LU0432979614.USD","SG9999002224.SGD","LU0098860793.USD","LU0211331839.USD","LU1066051498.USD","MRK","IE00B2B36J28.USD","LU1093756168.USD","LU2089984988.USD","IE0009355771.USD","LU0472753341.HKD","LU2357627491.SGD","LU2125154778.USD","LU0265550946.USD","LU0106261372.USD","LU2491050154.USD","LU0823416689.USD","LU0069063385.USD","LU2361045086.USD","LU1023059063.AUD","LU1201861249.SGD","SG9999001440.SGD","IE00BN8TJ469.HKD","LU1989772840.SGD","SG9999001176.SGD","LU0057025933.USD","LU1057294990.SGD","LU0320765646.SGD","LU0985320562.USD","IYH","LU1989771016.USD","LU0859254822.USD","LU1989772923.USD","LU0868494708.USD","SG9999015341.SGD","LU0238689110.USD","LU1699723380.USD","LU1929549753.HKD","SG9999013999.USD","LU1069347547.HKD","LU2361044949.HKD","LU1923622614.USD","LU2023250843.SGD","SG9999014567.USD","LU0124676726.USD","LU0965509283.SGD","LU2461242641.AUD","BK4534","IE00BLSP4239.USD","GDOC","LU0868494617.USD","BMED","JDOC","LU1093756325.SGD","IHE","BK4559","BK4139","IE00B4R5TH58.HKD","LU0861579265.USD","LU1061106388.HKD","SGXZ57979304.SGD","BK4007","LU0006306889.USD","LU0511384066.AUD","IE00BFTCPJ56.SGD","PAWZ","IE000M9KFDE8.USD","LU1066051811.HKD","LU0130517989.USD","LU0965509010.AUD","LU2491050071.SGD","BK4516","LU1291159041.SGD","LU1116320901.HKD","BK4533","LU1066051225.USD","LU1430594728.SGD","LU2324357040.USD","LU2361044865.SGD","LU1983299246.USD","SG9999015358.SGD","LU1035773651.USD","LU2125154935.USD","IE00BBT3K403.USD","LU1934455863.HKD","LU2125909247.SGD","LU2125909593.SGD","HRTS","BK4588","FHLC","LU1162221912.USD","LU1974910355.USD","SG9999001176.USD","LU0203345920.USD","LU1116320737.USD","LU1032466523.USD","BK4550","LU0122379950.USD","LU2023250504.SGD","LU0965508806.USD","LU2433249047.HKD","LU0130102774.USD","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","LU1037948897.HKD","LU0234572021.USD","LU2468319806.SGD","LU2106854487.HKD","LU0477156953.USD","LU0980610538.SGD","LU0689626769.HKD","LU0942090050.USD","LU1941712348.USD","SG9999014542.SGD","LU0289739343.SGD","LU0289961442.SGD","IE00BJJMRZ35.SGD","LU0265550359.USD","LU1934455194.USD","FTXH","LU0070302665.USD","SG9999014575.USD","LU2360032135.SGD","RXL","CATX","LU1571399168.USD","VHT","TRUH","LU0648001328.SGD","LU1585245621.USD","LU1917777945.USD","LU1066053197.SGD","LU1934455277.USD","LU2112291526.USD","LU2491049909.HKD","SG9999002232.USD","LU0965509101.SGD","LU0058720904.USD","LU0203347892.USD","LU1941712264.USD","LU0208291251.USD","LU1037948541.HKD","LU0289739699.SGD","LU0266013472.USD","BK4585","IE0002141913.USD","SG9999014559.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170311528","title":"CMS Secures Clinical Trial Green Light for Innovative Lupus Treatment Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1170311528","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170311528?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:26","pubTimestamp":1789381603,"startTime":"0","endTime":"0","summary":"CMS has announced that its innovative drug candidate, CMS-D001 tablets, received a clinical trial approval notice from China's National Medical Products Administration (NMPA) on September 11, 2026,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSYK","00867","LNGR","IE00BVYPNQ40.USD","BK1574","MEDX","SG9999015952.SGD","IE00BMCWC346.EUR","BK1593","06978","IE00BVYPNP33.GBP","MDTX","SG9999015945.SGD","IE00BGHQDM52.EUR","BMED","SG9999015986.USD","LU2488822045.USD","IBBJ","SG9999004311.SGD","SG9999015978.USD","IE00BYV24P56.USD","BK1161","SG9999004220.SGD","159992","BK1191","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667657930","title":"Perspective Therapeutics Partners with Merck to Test [212Pb]PSV359 with Keytruda in FAP-Α-Positive Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657930","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667657930?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:16","pubTimestamp":1789380980,"startTime":"0","endTime":"0","summary":"Perspective Therapeutics partners with Merck to test [212Pb]PSV359 with Keytruda in FAP-α-positive solid tumorsPerspective Therapeutics entered a clinical trial collaboration and supply agreement with","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL1Y3gl3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014575.USD","LU1929549753.HKD","LU0511384066.AUD","LU2461242641.AUD","PAWZ","SG9999001176.SGD","LU1934455194.USD","IHE","IE00BLSP4239.USD","LU0203347892.USD","BK4533","CATX","LU1291159041.SGD","SG9999014542.SGD","SG9999015358.SGD","IE00B4R5TH58.HKD","BK4139","LU0265550359.USD","LU1037948897.HKD","LU0289739699.SGD","SG9999014567.USD","LU1037948541.HKD","FTXH","SG9999015341.SGD","LU2361045086.USD","LU1941712348.USD","TRUH","IE00BFTCPJ56.SGD","LU0965509010.AUD","IE000M9KFDE8.USD","LU0965508806.USD","LU0823416689.USD","LU2023250843.SGD","LU2360032135.SGD","LU1941712264.USD","LU1116320737.USD","BK4516","LU0070302665.USD","LU1989772840.SGD","BK4007","IYH","LU0868494708.USD","LU2491050154.USD","LU1162221912.USD","LU0058720904.USD","LU1066051811.HKD","SG9999002232.USD","HRTS","LU0124676726.USD","LU0980610538.SGD","LU1032466523.USD","BK4534","IE00BLSP4452.SGD","LU0965509101.SGD","LU0689626769.HKD","LU2468319806.SGD","LU2357627491.SGD","IE00B1BXHZ80.USD","LU0266013472.USD","LU1116320901.HKD","LU0965509283.SGD","SG9999014559.SGD","LU0289739343.SGD","LU0265550946.USD","FHLC","BK4585","LU2089984988.USD","LU1093756168.USD","LU2491049909.HKD","LU1069347547.HKD","LU0203345920.USD","SGXZ57979304.SGD","LU0477156953.USD","LU1057294990.SGD","IE00B2B36J28.USD","LU2491050071.SGD","IE0009355771.USD","LU0208291251.USD","LU2125154778.USD","LU2324357040.USD","LU0069063385.USD","LU1923622614.USD","BK4550","BMED","LU0122379950.USD","LU0320765646.SGD","LU1974910355.USD","LU1989772923.USD","JDOC","LU0238689110.USD","SG9999013999.USD","LU0648001328.SGD","LU0006306889.USD","IE00BSNM7G36.USD","SG9999001176.USD","GDOC","LU2433249047.HKD","LU0211331839.USD","XLV","LU2125154935.USD","LU1571399168.USD","LU1430594728.SGD","LU0289961442.SGD","LU1201861249.SGD","LU1983299246.USD","LU1066051498.USD","LU1023059063.AUD","RXL","LU0942090050.USD","IE00BJT1NW94.SGD","LU2361044865.SGD","LU1035773651.USD","LU0868494617.USD","PPH","LU1989771016.USD","IE00BJJMRZ35.SGD","LU2106854487.HKD","LU0234572021.USD","LU2125909593.SGD","LU0057025933.USD","LU0861579265.USD","LU1585245621.USD","LU0472753341.HKD","LU1066051225.USD","BK4559","LU1066053197.SGD","LU0985320562.USD","LU1061106388.HKD","LU1917777945.USD","LU1699723380.USD","IE00BN8TJ469.HKD","LU2112291526.USD","LU2361044949.HKD","LU2125909247.SGD","LU0106261372.USD","LU0130517989.USD","LU0320765489.SGD","MRK","LU0130102774.USD","LU1934455277.USD","VHT","LU0098860793.USD","SG9999001440.SGD","BK4588","LU0859254822.USD","LU1934455863.HKD","LU2023250504.SGD","IE0002141913.USD","IXJ","SG9999002224.SGD","LU1093756325.SGD","IE00BBT3K403.USD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667265795","title":"Perspective Therapeutics, - Co Sponsors Study; Merck Provides Pembrolizumab at no Cost","url":"https://stock-news.laohu8.com/highlight/detail?id=2667265795","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667265795?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:16","pubTimestamp":1789380960,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA2TMQ2M:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0477156953.USD","LU2125909593.SGD","BMED","SG9999014567.USD","LU0124676726.USD","LU1037948897.HKD","LU0266013472.USD","LU0203345920.USD","LU1989772923.USD","LU1699723380.USD","LU0965508806.USD","BK4559","LU0234572021.USD","LU1585245621.USD","LU2023250843.SGD","LU1941712264.USD","LU0057025933.USD","LU1066051498.USD","LU0106261372.USD","LU1989771016.USD","BK4588","GDOC","LU0320765489.SGD","SG9999015358.SGD","CATX","BK4007","LU0861579265.USD","LU0868494708.USD","LU1116320737.USD","HRTS","BK4534","LU2361044949.HKD","LU2324357040.USD","BK4585","LU1941712348.USD","LU1430594728.SGD","LU1983299246.USD","LU0320765646.SGD","LU2023250504.SGD","LU0472753341.HKD","IE0009355771.USD","IYH","IE00B4R5TH58.HKD","LU2089984988.USD","LU0965509283.SGD","LU1923622614.USD","IE00BJJMRZ35.SGD","IE00BBT3K403.USD","LU2125154778.USD","LU0211331839.USD","LU0823416689.USD","IE00BJT1NW94.SGD","LU1934455277.USD","LU2112291526.USD","IE00BLSP4452.SGD","LU1066051225.USD","LU1571399168.USD","IE00B1BXHZ80.USD","JDOC","LU1162221912.USD","LU0432979614.USD","LU1093756168.USD","LU0006306889.USD","LU0130517989.USD","LU0511384066.AUD","LU0265550359.USD","LU2125154935.USD","LU0098860793.USD","LU1066051811.HKD","LU2491050154.USD","FHLC","LU0289739343.SGD","PAWZ","LU0208291251.USD","LU0868494617.USD","LU0859254822.USD","SG9999013999.USD","IE000M9KFDE8.USD","LU1934455194.USD","LU0985320562.USD","LU0689626769.HKD","LU0203347892.USD","LU1929549753.HKD","LU0980610538.SGD","SG9999001176.SGD","LU0122379950.USD","SG9999015341.SGD","XLV","LU0069063385.USD","LU1974910355.USD","FTXH","LU1066053197.SGD","LU0058720904.USD","BK4550","LU2433249047.HKD","VHT","LU0648001328.SGD","LU2360032135.SGD","SGXZ57979304.SGD","LU0289739699.SGD","LU0070302665.USD","IE00BFTCPJ56.SGD","MRK","IXJ","LU0130102774.USD","LU0265550946.USD","SG9999014559.SGD","LU2106854487.HKD","LU0238689110.USD","LU1023059063.AUD","LU1116320901.HKD","LU2491049909.HKD","LU1093756325.SGD","LU1032466523.USD","IE00BLSP4239.USD","LU1917777945.USD","LU2461242641.AUD","SG9999001440.SGD","RXL","LU1061106388.HKD","PPH","LU2468319806.SGD","LU1037948541.HKD","LU0965509010.AUD","LU1989772840.SGD","BK4533","LU1035773651.USD","IE00BN8TJ469.HKD","TRUH","SG9999002232.USD","SG9999001176.USD","LU0942090050.USD","IE0002141913.USD","LU1201861249.SGD","LU2357627491.SGD","LU1069347547.HKD","LU2491050071.SGD","SG9999014575.USD","LU1934455863.HKD","LU0965509101.SGD","LU1291159041.SGD","SG9999014542.SGD","BK4516","LU0289961442.SGD","IHE","LU2361045086.USD","IE00B2B36J28.USD","BK4139","LU2125909247.SGD","LU2361044865.SGD","LU1057294990.SGD","IE00BSNM7G36.USD","SG9999002224.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667652872","title":"Johnson & Johnson reports PAPILLON study meets primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2667652872","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667652872?lang=en_us&edition=fundamental","pubTime":"2026-09-14 17:35","pubTimestamp":1789378513,"startTime":"0","endTime":"0","summary":"Johnson & Johnson announced results from the final overall survival, or OS, analysis of the Phase 3 PAPILLON study evaluating first-line intravenou...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/johnson-johnson-reports-papillon-study-meets-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/johnson-johnson-reports-papillon-study-meets-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1935042991.SGD","BK4533","IE00B2B36J28.USD","LU1506573853.SGD","IE00BKVL7J92.USD","PJP","IXJ","VHT","MEDX","LU1280957306.USD","FTXH","LU0057025933.USD","IE0001KFT4U8.USD","LU0058720904.USD","LU0070217475.USD","LU0511384066.AUD","LU0345769128.USD","LU2347655156.SGD","IHE","BMED","LU0289739699.SGD","LU1914381329.SGD","LU1066053197.SGD","SGXZ57979304.SGD","FHLC","BK4007","LU0203347892.USD","LU1267930813.SGD","IE00B19Z3B42.SGD","SGXZ80539844.SGD","IE00BGHQF631.EUR","LU1221951046.USD","IYH","LU2129689431.USD","LU2505996509.AUD","LU2213496289.HKD","LU2756315318.SGD","LU0114720955.EUR","TRUH","IE000BZT7R73.USD","JNJ","RXL","GDOC","LU0964807845.USD","LU0545562505.USD","LU1629891620.HKD","LU0795875086.SGD","XLV","LU1228905037.USD","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667654231","title":"Market Chatter: Apollo Global in Talks to Buy J&J Orthopedics Unit for $20 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2667654231","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667654231?lang=en_us&edition=fundamental","pubTime":"2026-09-14 17:35","pubTimestamp":1789378500,"startTime":"0","endTime":"0","summary":"Apollo Global Management  is in talks to acquire Johnson & Johnson's  hips-and-knees business for about $20 billion, The Wall Street Journal reported Saturday, citing unnamed people familiar with the matter.The report said J&J has been seeking to separate its DePuy Synthes orthopedics unit, which generated $9.3 billion in sales last year.The talks with Apollo may not result in a deal, and other bidders could emerge, the report said.Apollo and J&J did not immediately respond MT Newswires' request for comment.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PJP","LU0640476718.USD","LU1551013342.USD","BK4592","GPZ","IE00BKVL7J92.USD","BMED","IE0002141913.USD","AAUM","BK4504","IHE","SG9999002224.SGD","APO","LU0210528500.USD","LU0820561818.USD","LU0289961442.SGD","LU2471134952.CNY","LU1323610961.USD","JDOC","LU1668664300.SGD","VHT","JNJ","LU1228905540.USD","LU2471134879.HKD","BK4534","LU0994945656.USD","LU1267930813.SGD","IXJ","TRUH","FHLC","RXL","IE00B3PB1722.GBP","MEDX","IE00BJT1NW94.SGD","LU2089984988.USD","GDOC","IE00BFTCPJ56.SGD","IE00BZ1G4Q59.USD","IYH","LU1043141123.HKD","LU1732800096.USD","XLV","LU0432979614.USD","LU0106831901.USD","PRVT","LBO","LU1066051811.HKD","LU0426417589.USD","LU1894683348.USD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667076654","title":"Nanobiotix announces updated safety, efficacy data from JNJ-1900 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2667076654","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667076654?lang=en_us&edition=fundamental","pubTime":"2026-09-14 17:20","pubTimestamp":1789377610,"startTime":"0","endTime":"0","summary":"Nanobiotix (NBTX) announced updated safety and efficacy data from the completed dose-escalation and expansion phases of a Phase 1 study sponsored b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanobiotix-announces-updated-safety-efficacy-data-from-jnj-1900-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanobiotix-announces-updated-safety-efficacy-data-from-jnj-1900-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IXJ","LU1732800096.USD","GDOC","SGXZ80539844.SGD","BK4504","BMED","FHLC","LU0210528500.USD","LU1066051811.HKD","FTXH","XLV","IE00BFTCPJ56.SGD","IYH","LU2471134879.HKD","LU0289961442.SGD","LU1267930813.SGD","IE00BJT1NW94.SGD","LU1551013342.USD","MEDX","LU2471134952.CNY","LU0994945656.USD","TRUH","LU1228905540.USD","LU0820562030.AUD","BK4139","JNJ","LU0432979614.USD","IE00B19Z3B42.SGD","IHE","IE0002141913.USD","LU0820561818.USD","RXL","LU0545562505.USD","IE00B3PB1722.GBP","PJP","LU0640476718.USD","SG9999002224.SGD","LU1894683348.USD","BK4592","BK4534","JDOC","IE00BZ1G4Q59.USD","LU2089984988.USD","LU0320765646.SGD","VHT","LU0426417589.USD","LU1929549753.HKD","LU1043141123.HKD","NBTX","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156243998","title":"AstraZeneca's Breast Cancer Drug Etcamah Hits A Phase 3 Setback, Clouding Billions In Potential Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=1156243998","media":"Options & Short Sell","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156243998?lang=en_us&edition=fundamental","pubTime":"2026-09-14 17:14","pubTimestamp":1789377246,"startTime":"0","endTime":"0","summary":"","market":"hk","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/1496.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/1496.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"AstraZeneca's Breast Cancer Drug Etcamah Hits a Phase 3 Setback, Clouding Billions in Potential Sales","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","RHHBY","MDTX","GPCR","AZN","IBBJ","ELIS","LLY","PFE","BMED","AMGN","VKTX","IBBQ","ELIL","NVOC","PSYK","NVO","LLYX","NVOX","LLII"],"isVideo":true,"video":{"duration":182,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/1496/render_1496_1789375598294.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/1496.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/1496/tts/voiceover_628d329bc79f3f40.mp3","isAI":true},"gpt_icon":0},{"id":"1128641476","title":"Etcamah Falls Short in Late-Stage Breast Cancer Trial, Clouding AstraZeneca's Sales Outlook for the Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1128641476","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128641476?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:44","pubTimestamp":1789375440,"startTime":"0","endTime":"0","summary":"AstraZeneca Plc (NASDAQ: AZN) announced on Friday that its Phase 3 SERENA-4 trial, evaluating the oral selective estrogen receptor degrader (SERD) Etcamah (camizestrant) in combination with...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","PSYK","BMED","IBBJ","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667373659","title":"Johnson & Johnson Says Lung Cancer Drug Combination Extends Median Survival to Over 34 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2667373659","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667373659?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:20","pubTimestamp":1789374055,"startTime":"0","endTime":"0","summary":"Johnson & Johnson  said Sunday a Phase 3 trial of its lung cancer drug Rybrevant combined with chemotherapy resulted in a median overall survival of 34.3 months.The treatment combination extended patient survival by more than six months compared to the 27.9-month median observed in the standalone chemotherapy group, the company said.An analysis adjusting for trial participants who switched to the experimental therapy after their disease progressed demonstrated a 43% lower risk of death, it said.The most common side effects from the treatment included paronychia, neutropenia, and rash, Johnson & Johnson said.Shares of the company were up over 1% in Monday premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B3T34201.USD","MEDX","LU1145028129.USD","IE00B2B36J28.USD","FHLC","JNJ","LU0058720904.USD","IXJ","IE00BSNM7G36.USD","BK4559","TRUH","LU1914381329.SGD","LU0545562505.USD","LU1674673428.USD","LU1929549753.HKD","IE0002270589.USD","LU0289739343.SGD","LU1066051225.USD","RXL","LU0289961442.SGD","LU1066053197.SGD","IE00B42XCP33.USD","IE00BJT1NW94.SGD","VHT","BK4007","LU2403377893.USD","LU1894683264.USD","IE00B19Z3581.USD","LU0320765646.SGD","XLV","LU1506573853.SGD","LU2602419157.SGD","GDOC","BMED","JDOC","LU1162221912.USD","LU0795875086.SGD","IE00B1BXHZ80.USD","LU0943347566.SGD","BK4568","LU0114720955.EUR","IHE","IYH","PJP","BK4550","LU0820561909.HKD","LU0426417589.USD","LU2112291526.USD","FTXH","BK4592"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}